Ranexa 375 mg
Ranexa 375 mg is a medicine authorised by Swissmedic under authorisation number 60533. The authorisation holder is A. Menarini GmbH. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 13 April 2010 and the authorisation is valid without a time limit. ATC code C01EB18 places the medicine in the group Cardiac therapy.
| Authorisation number | 60533 |
|---|---|
| Name | Ranexa 375 mg |
| Full name | Ranexa 375 mg, Retardtabletten |
| Authorisation holder | A. Menarini GmbH |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | C01EB18 |
| First authorisation | 13 April 2010 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Ranexa 375 mg, Retardtabletten | B | 13 April 2010 |
| 2 | Ranexa 500 mg, Retardtabletten | B | 13 April 2010 |
| 3 | Ranexa 750 mg, Retardtabletten | B | 13 April 2010 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 30 | Tablette(n) | C01EB18 | 02.99.0. | B |
| 2 | 60 | Tablette(n) | C01EB18 | 02.99.0. | B |
| 3 | 100 | Tablette(n) | C01EB18 | 02.99.0. | B |
| 4 | 30 | Tablette(n) | C01EB18 | 02.99.0. | B |
| 5 | 60 | Tablette(n) | C01EB18 | 02.99.0. | B |
| 6 | 100 | Tablette(n) | C01EB18 | 02.99.0. | B |
| 7 | 30 | Tablette(n) | C01EB18 | 02.99.0. | B |
| 8 | 60 | Tablette(n) | C01EB18 | 02.99.0. | B |
| 9 | 100 | Tablette(n) | C01EB18 | 02.99.0. | B |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Ranexa 375 mg authorised in Switzerland?
Yes. Ranexa 375 mg is authorised by Swissmedic under authorisation number 60533, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Ranexa 375 mg have?
Ranexa 375 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Ranexa 375 mg?
The authorisation holder is A. Menarini GmbH. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.